Literature DB >> 6499699

Ischaemic heart disease. An epidemiological perspective with special reference to electrolytes.

H Karppanen.   

Abstract

Ischaemic heart disease (IHD) is a major public health problem in most industrialised countries. In the death rates from IHD, marked differences exist between various countries and also between different areas of individual countries. Unfavourable dietary factors appear to play an important role in the aetiology of IHD, and thus differences in dietary habits and the quality of food may be mainly responsible for the geographic differences in the prevalence of IHD. The present liberal use of salt as well as the refining and other industrial processing of food increase the content of sodium and decrease the content of potassium and magnesium in the diet. The high intake of sodium and the inadequately low levels of potassium and magnesium in the diet predispose to the development of arterial hypertension. Since arterial hypertension is a major risk factor of IHD, the distorted electrolyte composition of our present diet can be considered an important aetiological factor of this disease. To decrease the body burden of sodium, diuretic agents are frequently used. Unfortunately, in the presence of the relatively low content of potassium and magnesium in the diet, the diuretic-induced increases in the excretion of these electrolytes commonly decrease the potassium and magnesium levels in the body. The falls in potassium and magnesium may increase the death rate from IHD by predisposing the heart to fatal arrhythmias, and also by other mechanisms. The likelihood of magnesium deficiency also appears to be influenced by the area of residence. The higher-than-average death rates from IHD in the so-called North Karelia area in eastern Finland and in some other areas with exceptionally high death rates from this disease may be at least partly due to the very low levels of magnesium in the soil and drinking water. It can be concluded that electrolyte disturbances have important implications in the aetiology and pathogenesis of IHD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499699     DOI: 10.2165/00003495-198400281-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  44 in total

1.  Goitre and arteriosclerosis.

Authors:  U UOTILA; J RAEKALLIO; W EHRNROOTH
Journal:  Lancet       Date:  1958-07-26       Impact factor: 79.321

2.  Urinary chromium excretion and atherosclerotic manifestations in two Finnish male populations.

Authors:  S Punsar; W Wolf; W Mertz; M J Karvonen
Journal:  Ann Clin Res       Date:  1977-04

Review 3.  Water hardness and cardiovascular diseases.

Authors:  G W Comstock
Journal:  Am J Epidemiol       Date:  1979-10       Impact factor: 4.897

4.  Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment.

Authors:  T Dyckner; P O Wester
Journal:  Am Heart J       Date:  1979-01       Impact factor: 4.749

5.  Effect of magnesium chloride on electrical stability of the heart.

Authors:  M F Ghani; M Rabah
Journal:  Am Heart J       Date:  1977-11       Impact factor: 4.749

Review 6.  High sodium-low potassium environment and hypertension.

Authors:  G R Meneely; H D Battarbee
Journal:  Am J Cardiol       Date:  1976-11-23       Impact factor: 2.778

7.  Magnesium and deaths ascribed to ischaemic heart disease in South Africa. A preliminary report.

Authors:  W P Leary; A J Reyes; C J Lockett; D D Arbuckle; K van der Byl
Journal:  S Afr Med J       Date:  1983-11-05

8.  Electrolyte output, blood pressure, and family history of hypertension.

Authors:  P I Pietinen; O Wong; A M Altschul
Journal:  Am J Clin Nutr       Date:  1979-05       Impact factor: 7.045

9.  Diuretic-associated hypomagnesaemia.

Authors:  J Sheehan; A White
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

10.  Magnesium deficiency in patients on long-term diuretic therapy for heart failure.

Authors:  P Lim; E Jacob
Journal:  Br Med J       Date:  1972-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.